Sign Up Today and Learn More About Tentarix Biotherapeutics Stock
Invest in or calculate the value of your shares in Tentarix Biotherapeutics or other pre-IPO companies through EquityZen's platform.
Tentarix Biotherapeutics Stock (TEBI)
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
About Tentarix Biotherapeutics Stock
Founded
2020
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Tentarix Biotherapeutics Press Mentions
Stay in the know about the latest news on Tentarix Biotherapeutics
AbbVie and Tentarix partner to develop oncology and immunology biologics
pmlive • Jun 05, 2024
Tentarix Biotherapeutics on LinkedIn: Introducing Dr. Andrew D. Kidd, the new Chief Executive Officer of… | 13 comments
linkedin • Jun 04, 2024
Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO
businesswire • May 23, 2024
Tentarix to collaborate with AbbVie on biologics research
thepharmaletter • Apr 09, 2024
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ...
prnewswire • Mar 01, 2024
Tentarix Biotherapeutics Management
Leadership team at Tentarix Biotherapeutics
Board of Directors
Paul Kang
Board of Directors
Srinivas Akkaraju
Join now and verify your accreditation status to gain access to:
- Tentarix Biotherapeutics current valuation
- Tentarix Biotherapeutics stock price
- Available deals in Tentarix Biotherapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Tentarix Biotherapeutics Stock
How to invest in Tentarix Biotherapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Tentarix Biotherapeutics through EquityZen funds. These investments are made available by existing Tentarix Biotherapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tentarix Biotherapeutics stock?
Shareholders can sell their Tentarix Biotherapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
